{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:42:51Z","timestamp":1793421771298,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1245\/s10434-007-9449-x","type":"journal-article","created":{"date-parts":[[2007,5,30]],"date-time":"2007-05-30T19:58:07Z","timestamp":1180555087000},"page":"3335-3344","source":"Crossref","is-referenced-by-count":136,"title":["Prophylactic Mastectomy in BRCA1\/2 Mutation Carriers and Women at Risk of Hereditary Breast Cancer: Long-Term Experiences at the Rotterdam Family Cancer Clinic"],"prefix":"10.1245","volume":"14","author":[{"given":"Bernadette A. M.","family":"Heemskerk-Gerritsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile T. M.","family":"Brekelmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian B. E.","family":"Menke-Pluymers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert N.","family":"van Geel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine M. A.","family":"Tilanus-Linthorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina C. M.","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murly","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne E. J.","family":"Meijers-Heijboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan G. M.","family":"Klijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Seynaeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,5,31]]},"reference":[{"key":"9449_CR1","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302:643\u20136","journal-title":"Science"},{"key":"9449_CR2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998; 62:676\u201389","journal-title":"Am J Hum Genet"},{"key":"9449_CR3","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Struewing","year":"1997","unstructured":"Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336:1401\u20138","journal-title":"N Engl J Med"},{"key":"9449_CR4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0140-6736(02)11023-3","volume":"360","author":"K Bergfeldt","year":"2002","unstructured":"Bergfeldt K, Rydh B, Granath F, Gronberg H, Thalib L, Adami HO, Hall P. Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study. Lancet 2002; 360:891\u20134","journal-title":"Lancet"},{"key":"9449_CR5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","volume":"345","author":"H Meijers-Heijboer","year":"2001","unstructured":"Meijers-Heijboer H, van Geel B, Van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2001; 345:159\u2013164","journal-title":"N Engl J Med"},{"key":"9449_CR6","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2004; 22:1055\u201362","journal-title":"J Clin Oncol"},{"key":"9449_CR7","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","volume":"93","author":"LC Hartmann","year":"2001","unstructured":"Hartmann LC, Sellers TA, Schaid DJ, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 2001; 93:1633\u20137","journal-title":"J Natl Cancer Inst"},{"key":"9449_CR8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","volume":"340","author":"LC Hartmann","year":"1999","unstructured":"Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999; 340:77\u201384","journal-title":"N Engl J Med"},{"key":"9449_CR9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2005.01.024","volume":"97","author":"PA Meeuwissen","year":"2005","unstructured":"Meeuwissen PA, Seynaeve C, Brekelmans CT, Meijers-Heijboer HJ, Klijn JG, Burger CW. Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer. Gynecol Oncol 2005; 97:476\u201382","journal-title":"Gynecol Oncol"},{"key":"9449_CR10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2004.02.013","volume":"93","author":"B Rosen","year":"2004","unstructured":"Rosen B, Kwon J, Fung Kee FM, Gagliardi A, Chambers A. Systematic review of management options for women with a hereditary predisposition to ovarian cancer. Gynecol Oncol 2004; 93:280\u20136","journal-title":"Gynecol Oncol"},{"key":"9449_CR11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1245\/ASO.2003.07.007","volume":"10","author":"AN Geel van","year":"2003","unstructured":"van Geel AN, Contant CM, Tjong Joe Wai R, Schmitz PI, Eggermont AM, Menke-Pluijmers MM. Mastectomy by inverted drip incision and immediate reconstruction: data from 510 cases. Ann Surg Oncol 2003; 10:389\u201395","journal-title":"Ann Surg Oncol"},{"key":"9449_CR12","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(00)02347-3","volume":"355","author":"EJ Meijers-Heijboer","year":"2000","unstructured":"Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT, et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 2000; 355:2015\u201320","journal-title":"Lancet"},{"key":"9449_CR13","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1200\/JCO.2003.09.052","volume":"21","author":"H Meijers-Heijboer","year":"2003","unstructured":"Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, et al. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol 2003; 21:1675\u201381","journal-title":"J Clin Oncol"},{"key":"9449_CR14","doi-asserted-by":"crossref","unstructured":"Klijn JGM, van Geel B, Meijers-Heijboer H, et al. Results of the extended series on prophylactic mastectomy versus surveillance in BRCA1\/2 mutation carriers in Rotterdam. Breast Cancer Res Treat 2004; 88[S10]. Ref Type: Abstract","DOI":"10.1200\/jco.2004.22.90140.9502"},{"key":"9449_CR15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1053\/ejso.2002.1279","volume":"28","author":"CM Contant","year":"2002","unstructured":"Contant CM, Menke-Pluijmers MB, Seynaeve C, et al. Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation. Eur J Surg Oncol 2002; 28:627\u201332","journal-title":"Eur J Surg Oncol"},{"key":"9449_CR16","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/01.prs.0000217383.99038.f5","volume":"117","author":"PJ Bresser","year":"2006","unstructured":"Bresser PJ, Seynaeve C, Van Gool AR, et al. Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women. Plast Reconstr Surg 2006; 117:1675\u201382","journal-title":"Plast Reconstr Surg"},{"key":"9449_CR17","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0959-8049(01)00244-1","volume":"37","author":"LC Verhoog","year":"2001","unstructured":"Verhoog LC, van den Ouweland AM, Berns E, et al. Large regional differences in the frequency of distinct BRCA1\/BRCA2 mutations in 517 Dutch breast and\/or ovarian cancer families. Eur J Cancer 2001; 37:2082\u201390","journal-title":"Eur J Cancer"},{"key":"9449_CR18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(97)07065-7","volume":"351","author":"LC Verhoog","year":"1998","unstructured":"Verhoog LC, Brekelmans CT, Seynaeve C, et al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 1998; 351:316\u201321","journal-title":"Lancet"},{"key":"9449_CR19","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1200\/JCO.1999.17.11.3396","volume":"17","author":"LC Verhoog","year":"1999","unstructured":"Verhoog LC, Brekelmans CT, Seynaeve C, et al. Survival in hereditary breast cancer associated with germline mutations of BRCA2. J Clin Oncol 1999; 17:3396\u20133402","journal-title":"J Clin Oncol"},{"key":"9449_CR20","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","volume":"343","author":"D Ford","year":"1994","unstructured":"Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994; 343:692\u20135","journal-title":"Lancet"},{"key":"9449_CR21","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2004.04.033","volume":"22","author":"K Metcalfe","year":"2004","unstructured":"Metcalfe K, Lynch HT, Ghadirian P, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 2004; 22:2328\u201335","journal-title":"J Clin Oncol"},{"key":"9449_CR22","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1200\/JCO.1998.16.5.1642","volume":"16","author":"M Robson","year":"1998","unstructured":"Robson M, Gilewski T, Haas B, et al. BRCA-associated breast cancer in young women. J Clin Oncol 1998; 16:1642\u20139","journal-title":"J Clin Oncol"},{"key":"9449_CR23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1054\/bjoc.2000.1239","volume":"83","author":"LC Verhoog","year":"2000","unstructured":"Verhoog LC, Brekelmans CT, Seynaeve C, Meijers-Heijboer EJ, Klijn JG. Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer. Br J Cancer 2000; 83:384\u20136","journal-title":"Br J Cancer"},{"key":"9449_CR24","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/cncr.21753","volume":"106","author":"K Shahedi","year":"2006","unstructured":"Shahedi K, Emanuelsson M, Wiklund F, Gronberg H. High risk of contralateral breast carcinoma in women with hereditary\/familial non-BRCA1\/BRCA2 breast carcinoma. Cancer 2006; 106:1237\u201342","journal-title":"Cancer"},{"key":"9449_CR25","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.ejca.2005.02.037","volume":"41","author":"YM Kirova","year":"2005","unstructured":"Kirova YM, Stoppa-Lyonnet D, Savignoni A, Sigal-Zafrani B, Fabre N, Fourquet A. Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. Eur J Cancer 2005; 41:2304\u201311","journal-title":"Eur J Cancer"},{"key":"9449_CR26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10549-005-9054-2","volume":"95","author":"MM Tilanus-Linthorst","year":"2006","unstructured":"Tilanus-Linthorst MM, Bartels KC, Alves C, et al. Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1\/2 patients. Breast Cancer Res Treat 2006; 95:117\u201323","journal-title":"Breast Cancer Res Treat"},{"key":"9449_CR27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1034\/j.1399-0004.2003.00097.x","volume":"64","author":"CI Scott","year":"2003","unstructured":"Scott CI, Iorgulescu DG, Thorne HJ, Henderson MA, Phillips KA. Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy. Clin Genet 2003; 64:111\u201321","journal-title":"Clin Genet"},{"key":"9449_CR28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.5858\/2000-124-0378-PMPFIH","volume":"124","author":"KK Khurana","year":"2000","unstructured":"Khurana KK, Loosmann A, Numann PJ, Khan SA. Prophylactic mastectomy: pathologic findings in high-risk patients. Arch Pathol Lab Med 2000; 124:378\u201381","journal-title":"Arch Pathol Lab Med"},{"key":"9449_CR29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1200\/JCO.2003.02.137","volume":"21","author":"N Hoogerbrugge","year":"2003","unstructured":"Hoogerbrugge N, Bult P, Widt-Levert LM, et al. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. J Clin Oncol 2003; 21:41\u20135","journal-title":"J Clin Oncol"},{"key":"9449_CR30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa031759","volume":"351","author":"M Kriege","year":"2004","unstructured":"Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004; 351:427\u201337","journal-title":"N Engl J Med"},{"key":"9449_CR31","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1200\/JCO.2004.00.4960","volume":"23","author":"CK Kuhl","year":"2005","unstructured":"Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005; 23:8469\u201376","journal-title":"J Clin Oncol"},{"key":"9449_CR32","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/cncr.22176","volume":"107","author":"JC Boughey","year":"2006","unstructured":"Boughey JC, Khakpour N, Meric-Bernstam F, et al. Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer 2006; 107:1440\u20137","journal-title":"Cancer"},{"key":"9449_CR33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/ejso.1999.0896","volume":"26","author":"CM Contant","year":"2000","unstructured":"Contant CM, van Geel AN, van der Holt B, Griep C, Tjong Joe Wai R, Wiggers T. Morbidity of immediate breast reconstruction (IBR) after mastectomy by a subpectorally placed silicone prosthesis: the adverse effect of radiotherapy. Eur J Surg Oncol 2000; 26:344\u201350","journal-title":"Eur J Surg Oncol"},{"key":"9449_CR34","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s10434-001-0586-3","volume":"8","author":"KY Lin","year":"2001","unstructured":"Lin KY, Johns FR, Gibson J, Long M, Drake DB, Moore MM. An outcome study of breast reconstruction: presurgical identification of risk factors for complications. Ann Surg Oncol 2001; 8:586\u201391","journal-title":"Ann Surg Oncol"},{"key":"9449_CR35","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/cncr.11757","volume":"98","author":"SM Zion","year":"2003","unstructured":"Zion SM, Slezak JM, Sellers TA, et al. Reoperations after prophylactic mastectomy with or without implant reconstruction. Cancer 2003; 98:2152\u201360","journal-title":"Cancer"},{"key":"9449_CR36","doi-asserted-by":"crossref","unstructured":"Barton MB, West CN, Liu IL, et al. Complications following bilateral prophylactic mastectomy. J Natl Cancer Inst Monogr 2005;61\u20136","DOI":"10.1093\/jncimonographs\/lgi039"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-007-9449-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T10:47:32Z","timestamp":1628938052000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-007-9449-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,31]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["9449"],"URL":"https:\/\/doi.org\/10.1245\/s10434-007-9449-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,31]]}}}